CTSK and osteoporosis: Thus, molecular docking was performed on previously identified major phenolic secondary metabolites obtained from Matricaria chamomilla L., in order to examine their potential inhibitory effect on cathepsin K. This enzyme has recently been recognized as a therapeutic target to treat osteoporosis and other disorders that are characterized by an elevation in bone resorption [22].